Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome
2020 · Nature Communications · 183 citations
https://doi.org/10.1038/s41467-020-19933-0
Y
Yu Jin Kim
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
1.5K
Citations
20
h-index
30
i10-index
Yu Jin Kim is an academic researcher from Johnson & Johnson (United States). The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Hepatitis C virus research & Lymphoma Diagnosis and Treatment. The author has an h-index of 20, co-authored 46 publications.
Papers by this author
worksThe forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
2014 · Breast Cancer Research · 131 citations
https://doi.org/10.1186/s13058-014-0436-4
CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
2015 · PLoS ONE · 89 citations
https://doi.org/10.1371/journal.pone.0139112
Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (<i>ALK</i>)<i>‐</i>rearranged non‐small cell lung cancer
2017 · The Journal of Pathology · 78 citations
https://doi.org/10.1002/path.4950
Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology
2019 · Laboratory Investigation · 33 citations
https://doi.org/10.1038/s41374-019-0263-4
Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling
2014 · Scientific Reports · 31 citations
https://doi.org/10.1038/srep03623
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat